540 related articles for article (PubMed ID: 37470673)
1. Proton pump inhibitor use associated with an increased risk of gout: A population-based case-control study.
Zhu KJ; Feng W; Ma XN; Liao PL; Lin CS; Huang JY; Wei JC; Xu Q
Int J Rheum Dis; 2023 Sep; 26(9):1799-1806. PubMed ID: 37470673
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
3. The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.
Song HJ; Park H; Park S; Kwon JW
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):830-839. PubMed ID: 30920070
[TBL] [Abstract][Full Text] [Related]
4. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
Park JH; Song YM; Jung JH; Han K
Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
[TBL] [Abstract][Full Text] [Related]
6. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study.
Yee J; Han HW; Gwak HS
Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788
[TBL] [Abstract][Full Text] [Related]
8. The association between chronic rhinosinusitis and proton pump inhibitor use: a nested case-control study using a health screening cohort.
Choi HG; Kong IG
Sci Rep; 2022 Jun; 12(1):9554. PubMed ID: 35689002
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
11. Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals.
Nguyen NTH; Huang CW; Wang CH; Lin MC; Hsu JC; Hsu MH; Iqbal U; Nguyen PA; Yang HC
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551573
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
13. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
Wang WT; Li CY; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chiou SH; Chen MH
Allergy Asthma Proc; 2023 Sep; 44(5):345-353. PubMed ID: 37641222
[No Abstract] [Full Text] [Related]
14. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
Chen HY; Lin JJ; Yang B; Lin MC
Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
[TBL] [Abstract][Full Text] [Related]
15. Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study.
Dai YX; Tai YH; Chen CC; Chang YT; Chen TJ; Chen MH
J Dermatol; 2020 Oct; 47(10):1126-1130. PubMed ID: 32613686
[TBL] [Abstract][Full Text] [Related]
16. Association between Benign Paroxysmal Positional Vertigo and Previous Proton Pump Inhibitor Use: A Nested Case-Control Study Using a National Health Screening Cohort.
Kim SY; Yoo DM; Kwon MJ; Kim JH; Kim JH; Lee JS; Choi HG
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011915
[TBL] [Abstract][Full Text] [Related]
17. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.
Wang KN; Bell JS; Tan ECK; Gilmartin-Thomas JFM; Dooley MJ; Ilomäki J
Drugs Aging; 2019 Nov; 36(11):1027-1034. PubMed ID: 31485926
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia.
Issa I; Skov J; Falhammar H; Calissendorff J; Lindh JD; Mannheimer B
Eur J Clin Pharmacol; 2023 Jan; 79(1):71-77. PubMed ID: 36380227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]